Anixa Biosciences annual operating margin
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2021
2023
2024
Anixa Biosciences Operating Margin Growth & History (ANIX)
Anixa Biosciences's operating margin was −6,586.19% for fiscal 2024.
View full Anixa Biosciences company overviewAnixa Biosciences annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-10-31 | −6,586.19% | −1342.86 pp |
| 2023 | 2023-10-31 | −5,243.33% | −2677.71 pp |
| 2021 | 2021-10-31 | −2,565.63% | +2190.38 pp |
| 2019 | 2019-10-31 | −4,756.00% | −3471.59 pp |
| 2018 | 2018-10-31 | −1,284.41% | +391.61 pp |
| 2017 | 2017-10-31 | −1,676.02% | −173.02 pp |
| 2016 | 2016-10-31 | −1,503.00% | −1492.80 pp |
| 2015 | 2015-10-31 | −10.21% | +127.33 pp |
| 2014 | 2014-10-31 | −137.54% | +1898.63 pp |
| 2013 | 2013-10-31 | −2,036.17% | −1596.33 pp |
| 2012 | 2012-10-31 | −439.84% | +61.38 pp |
| 2011 | 2011-10-31 | −501.23% | +217.04 pp |
| 2010 | 2010-10-31 | −718.27% | — |
Anixa Biosciences quarterly operating margin
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q1.13
Q4.13
Q2.14
Q3.14
Q1.15
Q2.15
Q3.15
Q3.16
Q3.17
Q2.18
Q3.18
Q2.19
Q1.21
Q1.22
Q2.23
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2023 | 2023-04-30 | −1,219.05% | +327.38 pp |
| Q1 2022 | 2022-01-31 | −756.34% | −569.54 pp |
| Q1 2021 | 2021-01-31 | −435.28% | +42.21 pp |
| Q2 2019 | 2019-04-30 | −1,037.29% | −62.41 pp |
| Q3 2018 | 2018-07-31 | −1,546.43% | +22.75 pp |
| Q2 2018 | 2018-04-30 | −186.79% | +8346.16 pp |
| Q3 2017 | 2017-07-31 | −477.50% | −519.72 pp |
| Q3 2016 | 2016-07-31 | −974.88% | −961.44 pp |
| Q3 2015 | 2015-07-31 | −1,569.18% | −1446.53 pp |
| Q2 2015 | 2015-04-30 | −8,532.95% | −8073.91 pp |
| Q1 2015 | 2015-01-31 | 42.22% | +97356.73 pp |
| Q3 2014 | 2014-07-31 | −13.44% | +244.44 pp |
| Q2 2014 | 2014-04-30 | −122.65% | +231.36 pp |
| Q4 2013 | 2013-10-31 | −459.05% | −261.53 pp |
| Q1 2013 | 2013-01-31 | −97,314.51% | −97090.23 pp |
| Q3 2012 | 2012-07-31 | −257.88% | +10.27 pp |
| Q2 2012 | 2012-04-30 | −354.01% | +1127.38 pp |
| Q1 2012 | 2012-01-31 | −197.52% | +8802.00 pp |
| Q4 2011 | 2011-10-31 | −224.28% | +1964.70 pp |
| Q3 2011 | 2011-07-31 | −268.15% | — |
| Q2 2011 | 2011-04-30 | −1,481.39% | — |
| Q1 2011 | 2011-01-31 | −8,999.52% | — |
| Q3 2010 | 2010-07-31 | −2,188.97% | — |
Anixa Biosciences operating margin trends
Over the last five reported fiscal years, Anixa Biosciences's operating margin decreased from −1,676.02% to −6,586.19%, a change of −4910.17 percentage points. The latest reported quarter, Q2 2023, shows −1,219.05%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Anixa Biosciences filings at SEC.gov ↗